← USPTO Patent Applications

ISOQUINOLONES AS PI3K INHIBITORS

Application US20260078103A1 Kind: A1 Mar 19, 2026

Assignee

OnKure, Inc.

Inventors

James F. BLAKE, Mark Laurence BOYS, David A. MARESKA, Joshua Nathaniel PAYETTE, Christie A. SCHULTE, Bryan YESTREPSKY, Qian ZHAO

Abstract

Novel PI3K inhibitors of the general formula (1) are described along with methods of their preparation and their use in the treatment of diseases associated with the elevation or activation of the PI3K pathway, wherein R1 to R8 are as defined.

CPC Classifications

C07D 401/04 A61K 31/4725 A61K 31/496 A61K 31/497 A61K 31/4985 A61K 31/4995 A61K 31/501 A61K 31/506 A61K 31/519 A61K 31/5377 A61K 31/541 A61K 31/675 C07D 217/24 C07D 401/12 C07D 401/14 C07D 405/04 C07D 405/14 C07D 413/04 C07D 413/14 C07D 417/04 C07D 417/14 C07D 451/02 C07D 471/04 C07D 471/08 C07D 471/10 C07D 487/04 C07D 487/08 C07D 487/10 C07D 491/048 C07D 491/107 C07D 498/04 C07D 513/04 C07F 9/6584

Filing Date

2023-09-06

Application No.

19107476